Back to NewEdge Advisors, LLC NewEdge Advisors, LLC

CRBPCRBP
15 quarters

Position history for NewEdge Advisors, LLCNewEdge Advisors, LLC's holdings in CORBUS PHARMACEUTICALS HLDGS

NewEdge Advisors, LLC holds 8 shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), worth $75 as of 2026-Q2.

Current Value

$75

Current Shares

8

Total Value Change

+$75

Total Shares Change

-242

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
8
0.0%
$750.0%$9.38
0
2026-Q1
Unchanged
8
0.0%
$750.0%$8.21
0
2025-Q4
Unchanged
8
0.0%
$650.0%$8.01
0
2025-Q3
Unchanged
8
0.0%
$1010.0%$12.26
0
2025-Q2
Decreased
8
-11.1%
$550.0%$7.40
0
2025-Q1
Increased
9
+12.5%
$470.0%$5.52
9
2024-Q4
Decreased
8
-99.9%
$940.0%$12.08
0
2024-Q3
Increased
6,576
+0.1%
$135,6640.0%$20.92
22
2024-Q2
Increased
6,568
+820x
$297,2060.0%$45.25
38
2024-Q1
Unchanged
8
0.0%
$3140.0%$39.24
0
2023-Q4
Unchanged
8
0.0%
$480.0%$6.04
0
2023-Q3
Unchanged
8
0.0%
$540.0%$6.74
0
2023-Q2
Unchanged
8
0.0%
$630.0%$8.00
0
2023-Q1
Decreased
8
-96.8%
$580.0%$8.83
0
2022-Q4
New
250
-
$00.0%$3.33
17

Other major holders of CRBP: BlackRock Finance, Inc., Point72 Asset Management, L.P., STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., D. E. Shaw & Co., Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used